GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $38,057,000 | +112.1% | 2,606,636 | +106.3% | 0.44% | +75.8% |
| Q3 2020 | $17,946,000 | -18.1% | 1,263,811 | -15.1% | 0.25% | -20.0% |
| Q2 2020 | $21,907,000 | +120.5% | 1,489,284 | -38.3% | 0.31% | +60.6% |
| Q1 2020 | $9,937,000 | -15.4% | 2,411,926 | -1.2% | 0.19% | +3.8% |
| Q4 2019 | $11,742,000 | -14.5% | 2,441,241 | +7.7% | 0.19% | -27.3% |
| Q3 2019 | $13,740,000 | -10.0% | 2,267,252 | -3.6% | 0.26% | -1.9% |
| Q2 2019 | $15,271,000 | -8.5% | 2,353,067 | 0.0% | 0.26% | -71.6% |
| Q1 2019 | $16,683,000 | +71.7% | 2,353,067 | +17.7% | 0.92% | +43.7% |
| Q4 2018 | $9,718,000 | -1.3% | 1,999,540 | +49.3% | 0.64% | +2.2% |
| Q3 2018 | $9,845,000 | +30.1% | 1,339,502 | +12.9% | 0.62% | -3.1% |
| Q2 2018 | $7,570,000 | +17.3% | 1,186,502 | 0.0% | 0.64% | +0.8% |
| Q1 2018 | $6,455,000 | +100.1% | 1,186,502 | +53.4% | 0.64% | +89.9% |
| Q4 2017 | $3,226,000 | -36.0% | 773,677 | +47.7% | 0.34% | -36.1% |
| Q3 2017 | $5,043,000 | +5.2% | 523,677 | +29.2% | 0.53% | -7.1% |
| Q2 2017 | $4,793,000 | +19.6% | 405,178 | +29.6% | 0.57% | +6.2% |
| Q1 2017 | $4,008,000 | – | 312,666 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|